Review article: intestinal metaplasia and gastric carcinogenesis (Q34764688)

4 August 2017

1 reference

title

Review article: intestinal metaplasia and gastric carcinogenesis (English)

1 reference

4 August 2017

1 reference

1 reference

Leung WK

1

1 reference

PubMed ID

12144569

4 August 2017

Sung JJ

series ordinal

2

1 reference

PubMed ID

12144569

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Alimentary Pharmacology & Therapeutics

4 August 2017

1 reference

4 August 2017

16

1 reference

4 August 2017

1209-1216

1 reference

4 August 2017

7

1 reference

Intestinal metaplasia of the stomach. A status report

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Review article: pre-neoplastic states of the gastric mucosa--a practical approach for the perplexed clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

The risk of stomach cancer in patients with gastric or duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

A model for gastric cancer epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Helicobacter pylori genotypes may determine gastric histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Induction of gastric epithelial apoptosis by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Apoptosis and proliferation in Helicobacter pylori-associated gastric intestinal metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Review article: cyclooxygenase--a target for colon cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

The long term results of endoscopic surveillance of premalignant gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Preventing cancer by disrupting progression of precancerous lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01300.X

10.1046/J.1365-2036.2002.01300.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12144569